Dengue Vaccine Global Market Report 2025

Global Dengue Vaccine Market Report 2024

Dengue Vaccine Global Market Report 2025 – By Type (Live Attenuated Vaccine, Chimeric Live Attenuated Vaccine, Inactivated Vaccine, Subunit Vaccine, Nucleic Acid Based Vaccine), By Vaccine Phase (Phase I, Phase II, Phase III), By Treatment (Diuretic, Anti-Allergic, Blood Thinners, Other Treatments), By Route Of Administration (Oral, Parenteral, Other Routes Of Administration), By End-User (Hospitals, Clinics, Government Institutes, Non-Governmental Organizations, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

Name: Dengue Vaccine Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Dengue Vaccine Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Dengue Vaccine Global Market Report 2025

Proud Members Of

Dengue Vaccine Market Definition

A dengue vaccine is a biological preparation designed to prevent dengue fever, a mosquito-borne viral disease caused by the dengue virus (DENV). If exposed in the future, dengue vaccines stimulate the body's immune system to recognize and fight off the dengue virus.

The main types of dengue vaccines are live attenuated vaccine, chimeric live attenuated vaccine, inactivated vaccine, subunit vaccine, and nucleic acid-based vaccine. Live-attenuated vaccines use a weakened virus to trigger an immune response, preparing the body to combat dengue without causing the disease. It includes different vaccine phases, such as phase I, phase II, and phase III, with treatment including diuretics, anti-allergics, blood thinners, and others. It is administered through several routes of administration, such as oral, parenteral, and others, and used by end-user hospitals, clinics, government institutes, non-governmental organizations, and others.

Dengue Vaccine Market Segmentation

The dengue vaccinemarket covered in this report is segmented –

1) By Type: Live Attenuated Vaccine, Chimeric Live Attenuated Vaccine, Inactivated Vaccine, Subunit Vaccine, Nucleic Acid Based Vaccine

2) By Vaccine Phase: Phase I, Phase II, Phase III

3) By Treatment: Diuretic, Anti-Allergic, Blood Thinners, Other Treatments

4) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration

5) By End-User: Hospitals, Clinics, Government Institutes, Non-Governmental Organizations, Other End-Users

Subsegments:

1) By Live Attenuated Vaccine: Single Strain, Multi-Strain

2) By Chimeric Live Attenuated Vaccine: Tetravalent Chimeric Vaccine, Monovalent Chimeric Vaccine

3) By Inactivated Vaccine: Whole Virus Inactivated Vaccine, Split Virus Vaccine

4) By Subunit Vaccine: Recombinant Protein Vaccine, Peptide-Based Vaccine

5) By Nucleic Acid Based Vaccine: DNA Vaccine, mRNA Vaccine

Dengue Vaccine Market Size and growth rate 2025 to 2029: Graph

Dengue Vaccine Market Size 2025 And Growth Rate

The dengue vaccine market size has grown rapidly in recent years. It will grow from $0.64 billion in 2024 to $0.72 billion in 2025 at a compound annual growth rate (CAGR) of 12.4%. The growth in the historic period can be attributed to growing travel and urbanization, increasing demand for effective vaccines, increasing prevalence of foreign travel exposure, increasing healthcare services, and rising mass vaccinations.

Dengue Vaccine Market Growth Forecast

The dengue vaccine market size is expected to see rapid growth in the next few years. It will grow to $1.14 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to the increasing incidence of dengue, increasing initiatives by several organizations, increasing clinical trials, and growing emphasis on multi-strain and tetravalent vaccine formulations. Major trends in the forecast period include increasing demand for preventative vaccines, advancements in vaccine technology, development of combination vaccines, rise in research and clinical trials for new vaccine candidates, and focus on improving vaccine efficacy and safety profiles.

Book your 30 minutes free consultation with our research experts

Dengue Vaccine Market Driver: Surge In Dengue Fever Cases Fuels Growth In The Dengue Vaccine Market

The rising number of dengue fever cases is expected to propel the growth of the dengue vaccine markets going forward. Dengue fever is a viral infection spread by Aedes aegypti mosquitoes, causing high fever, headaches, joint pain, and rashes. The rise in dengue fever cases is due to climate change, urbanization, inadequate mosquito control, and viral evolution. The dengue vaccine works by activating the immune system to identify and combat the dengue virus. It lessens infection severity and reduces the risk of severe complications, helping to decrease cases and hospitalizations. For instance, in May 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, in the American region, dengue cases surpassed 7 million in April 2024, from 4.6 million cases reported in 2023. Therefore, the rising number of dengue fever cases is driving the growth of the dengue vaccine market.

Global Dengue Vaccine Market Major Players

Major companies operating in the dengue vaccine market are Merck & Co. Inc., Sanofi Pasteur Limited, GlaxoSmithKline plc, Takeda Pharmaceutical Company, Sun Pharmaceutical Industries Ltd., Biological E. Limited, Saint Louis University, Indian Immunologicals Limited, Serum Institute of India Pvt. Ltd., Bavarian Nordic, Instituto Butantan, Bharat Biotech Ltd., Panacea Biotec Limited, SABIN Vaccine Institute, Medigen Vaccine Biologics Corporation, Emergex Vaccines Holding Ltd., BioNet-Asia Co. Ltd., Codagenix Inc., KM Biologics Co. Ltd., Chula Vaccine Research Center, Imutex Ltd.

Global Dengue Vaccine Market Trend: Advancements In Dengue Tetravalent Vaccines Enhance Comprehensive Protection Against All Serotypes

Major companies operating in the dengue vaccine market are focused on developing advanced vaccine formulations, such as the dengue tetravalent vaccine, to enhance protection against all four dengue virus serotypes in a single formulation. The dengue tetravalent vaccine provides immunity against all four dengue virus serotypes (DEN-1, DEN-2, DEN-3, and DEN-4), offering comprehensive protection against dengue fever. For instance, in December 2022, Takeda Pharmaceutical Company, a Japan-based pharmaceutical company, received European Commission (EC) approval for QDENGA vaccine use in individuals from 4 years of age and older. It is a live-attenuated vaccine used in several dengue-endemic countries to protect against dengue fever. It uses a weakened dengue serotype two viruses as a genetic foundation for the other three serotypes. It is administered in two doses of 0.5 mL each at 0 and 3 months and targets individuals aged four years and older. A Phase 3 trial showed Qdenga has an efficacy of about 80.2% against dengue, with better results in preventing hospitalizations. Its protection lasts approximately 4.5 years, longer than many other vaccines.

Dengue Vaccine Market Merger And Acquisition: Takeda Partnered With Biological E. Limited To Boost Dengue Vaccine Production And Accessibility

In February 2024, Takeda Pharmaceutical Company, a Japan-based manufacturer of dengue vaccine, partnered with Biological E. Limited. Through this collaboration, Takeda aims to accelerate the production and accessibility of the dengue vaccine QDENGA (TAK-003) in endemic regions by increasing manufacturing capacity and providing multi-dose vials to support national immunization programs. Biological E. Limited is an India-based biotechnology and biopharmaceutical company specializing in producing and supplying vaccines and therapeutics.

Regional Outlook For The Global Dengue Vaccine Market

Asia-Pacific was the largest region in the dengue vaccine market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the dengue vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the dengue vaccine market report areAustralia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Dengue Vaccine Market?

The dengue vaccine market consists of revenues earned by entities by providing treatment such as chlorothiazide, chlorthalidone, hydrochlorothiazide, and fexofenadine. The market value includes the value of related goods sold by the service provider or included within the service offering. The dengue vaccine market also includes sales of diagnostic kits, combination vaccines, clinical trial products, and post-vaccination monitoring tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Dengue Vaccine Industry?

The dengue vaccines market research report is one of a series of new reports from The Business Research Company that provides dengue vaccines market statistics, including dengue vaccines industry global market size, regional shares, competitors with a dengue vaccines market share, detailed dengue vaccines market segments, market trends, and opportunities, and any further data you may need to thrive in the dengue vaccines industry. This dengue vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Dengue Vaccine Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$0.72 billion
Revenue Forecast In 2034	$1.14 billion
Growth Rate	CAGR of 12.3% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Type: Live Attenuated Vaccine, Chimeric Live Attenuated Vaccine, Inactivated Vaccine, Subunit Vaccine, Nucleic Acid Based Vaccine 2) By Vaccine Phase: Phase I, Phase II, Phase III 3) By Treatment: Diuretic, Anti-Allergic, Blood Thinners, Other Treatments 4) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration 5) By End-User: Hospitals, Clinics, Government Institutes, Non-Governmental Organizations, Other End-Users Subsegments: 1) By Live Attenuated Vaccine: Single Strain, Multi-Strain 2) By Chimeric Live Attenuated Vaccine: Tetravalent Chimeric Vaccine, Monovalent Chimeric Vaccine 3) By Inactivated Vaccine: Whole Virus Inactivated Vaccine, Split Virus Vaccine 4) By Subunit Vaccine: Recombinant Protein Vaccine, Peptide-Based Vaccine 5) By Nucleic Acid Based Vaccine: DNA Vaccine, mRNA Vaccine
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Merck & Co. Inc., Sanofi Pasteur Limited, GlaxoSmithKline plc, Takeda Pharmaceutical Company, Sun Pharmaceutical Industries Ltd., Biological E. Limited, Saint Louis University, Indian Immunologicals Limited, Serum Institute of India Pvt. Ltd., Bavarian Nordic, Instituto Butantan, Bharat Biotech Ltd., Panacea Biotec Limited, SABIN Vaccine Institute, Medigen Vaccine Biologics Corporation, Emergex Vaccines Holding Ltd., BioNet-Asia Co. Ltd., Codagenix Inc., KM Biologics Co. Ltd., Chula Vaccine Research Center, Imutex Ltd.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Dengue Vaccine Market Characteristics

3. Dengue Vaccine Market Trends And Strategies

4. Dengue Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Dengue Vaccine Growth Analysis And Strategic Analysis Framework

5.1. Global Dengue Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Dengue Vaccine Market Growth Rate Analysis

5.4. Global Dengue Vaccine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Dengue Vaccine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Dengue Vaccine Total Addressable Market (TAM)

6. Dengue Vaccine Market Segmentation

6.1. Global Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Live Attenuated Vaccine

Chimeric Live Attenuated Vaccine

Inactivated Vaccine

Subunit Vaccine

Nucleic Acid Based Vaccine

6.2. Global Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Phase I

Phase II

Phase III

6.3. Global Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Diuretic

Anti-Allergic

Blood Thinners

Other Treatments

6.4. Global Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Parenteral

Other Routes Of Administration

6.5. Global Dengue Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinics

Government Institutes

Non-Governmental Organizations

Other End-Users

6.6. Global Dengue Vaccine Market, Sub-Segmentation Of Live Attenuated Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Single Strain

Multi-Strain

6.7. Global Dengue Vaccine Market, Sub-Segmentation Of Chimeric Live Attenuated Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tetravalent Chimeric Vaccine

Monovalent Chimeric Vaccine

6.8. Global Dengue Vaccine Market, Sub-Segmentation Of Inactivated Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Whole Virus Inactivated Vaccine

Split Virus Vaccine

6.9. Global Dengue Vaccine Market, Sub-Segmentation Of Subunit Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Recombinant Protein Vaccine

Peptide-Based Vaccine

6.10. Global Dengue Vaccine Market, Sub-Segmentation Of Nucleic Acid Based Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

DNA Vaccine

mRNA Vaccine

7. Dengue Vaccine Market Regional And Country Analysis

7.1. Global Dengue Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Dengue Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Dengue Vaccine Market

8.1. Asia-Pacific Dengue Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Dengue Vaccine Market

9.1. China Dengue Vaccine Market Overview

9.2. China Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Dengue Vaccine Market

10.1. India Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Dengue Vaccine Market

11.1. Japan Dengue Vaccine Market Overview

11.2. Japan Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Dengue Vaccine Market

12.1. Australia Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Dengue Vaccine Market

13.1. Indonesia Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Dengue Vaccine Market

14.1. South Korea Dengue Vaccine Market Overview

14.2. South Korea Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Dengue Vaccine Market

15.1. Western Europe Dengue Vaccine Market Overview

15.2. Western Europe Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Dengue Vaccine Market

16.1. UK Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Dengue Vaccine Market

17.1. Germany Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Dengue Vaccine Market

18.1. France Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Dengue Vaccine Market

19.1. Italy Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Dengue Vaccine Market

20.1. Spain Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Dengue Vaccine Market

21.1. Eastern Europe Dengue Vaccine Market Overview

21.2. Eastern Europe Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Dengue Vaccine Market

22.1. Russia Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Dengue Vaccine Market

23.1. North America Dengue Vaccine Market Overview

23.2. North America Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Dengue Vaccine Market

24.1. USA Dengue Vaccine Market Overview

24.2. USA Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Dengue Vaccine Market

25.1. Canada Dengue Vaccine Market Overview

25.2. Canada Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Dengue Vaccine Market

26.1. South America Dengue Vaccine Market Overview

26.2. South America Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Dengue Vaccine Market

27.1. Brazil Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Dengue Vaccine Market

28.1. Middle East Dengue Vaccine Market Overview

28.2. Middle East Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Dengue Vaccine Market

29.1. Africa Dengue Vaccine Market Overview

29.2. Africa Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Dengue Vaccine Market Competitive Landscape And Company Profiles

30.1. Dengue Vaccine Market Competitive Landscape

30.2. Dengue Vaccine Market Company Profiles

30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Sanofi Pasteur Limited Overview, Products and Services, Strategy and Financial Analysis

30.2.3. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Takeda Pharmaceutical Company Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Dengue Vaccine Market Other Major And Innovative Companies

31.1. Biological E. Limited

31.2. Saint Louis University

31.3. Indian Immunologicals Limited

31.4. Serum Institute of India Pvt. Ltd.

31.5. Bavarian Nordic

31.6. Instituto Butantan

31.7. Bharat Biotech Ltd.

31.8. Panacea Biotec Limited

31.9. SABIN Vaccine Institute

31.10. Medigen Vaccine Biologics Corporation

31.11. Emergex Vaccines Holding Ltd.

31.12. BioNet-Asia Co. Ltd.

31.13. Codagenix Inc.

31.14. KM Biologics Co. Ltd.

31.15. Chula Vaccine Research Center

32. Global Dengue Vaccine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Dengue Vaccine Market

34. Recent Developments In The Dengue Vaccine Market

35. Dengue Vaccine Market High Potential Countries, Segments and Strategies

35.1 Dengue Vaccine Market In 2029 - Countries Offering Most New Opportunities

35.2 Dengue Vaccine Market In 2029 - Segments Offering Most New Opportunities

35.3 Dengue Vaccine Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Dengue Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Dengue Vaccine Market, Sub-Segmentation Of Live Attenuated Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Dengue Vaccine Market, Sub-Segmentation Of Chimeric Live Attenuated Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Dengue Vaccine Market, Sub-Segmentation Of Inactivated Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Dengue Vaccine Market, Sub-Segmentation Of Subunit Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Dengue Vaccine Market, Sub-Segmentation Of Nucleic Acid Based Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Dengue Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Global Dengue Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: Asia-Pacific, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: China, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: India, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Japan, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Australia, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Indonesia, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: South Korea, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Western Europe, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: UK, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Germany, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: France, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Italy, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Spain, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Eastern Europe, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: Russia, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: North America, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: USA, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Canada, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: South America, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Brazil, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Middle East, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Africa, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 81: Merck & Co. Inc. Financial Performance

Table 82: Sanofi Pasteur Limited Financial Performance

Table 83: GlaxoSmithKline plc Financial Performance

Table 84: Takeda Pharmaceutical Company Financial Performance

Table 85: Sun Pharmaceutical Industries Ltd. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Dengue Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Dengue Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Dengue Vaccine Market, Sub-Segmentation Of Live Attenuated Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Dengue Vaccine Market, Sub-Segmentation Of Chimeric Live Attenuated Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Dengue Vaccine Market, Sub-Segmentation Of Inactivated Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Dengue Vaccine Market, Sub-Segmentation Of Subunit Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Dengue Vaccine Market, Sub-Segmentation Of Nucleic Acid Based Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Dengue Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Global Dengue Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: Asia-Pacific, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: China, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: India, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Japan, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Australia, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Indonesia, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: South Korea, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Western Europe, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: UK, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Germany, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: France, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Italy, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Spain, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Eastern Europe, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: Russia, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: North America, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: USA, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Canada, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: South America, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Brazil, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Middle East, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Dengue Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Dengue Vaccine Market, Segmentation By Vaccine Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Africa, Dengue Vaccine Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 81: Merck & Co. Inc. Financial Performance

Figure 82: Sanofi Pasteur Limited Financial Performance

Figure 83: GlaxoSmithKline plc Financial Performance

Figure 84: Takeda Pharmaceutical Company Financial Performance

Figure 85: Sun Pharmaceutical Industries Ltd. Financial Performance

Opportunities And Strategies Analysis For The Forestry And Logging Market – Includes Forestry And Logging Market Size

Opportunities And Strategies Analysis For The Genetically Modified Crops Market – Includes Genetically Modified Crops Market Size

The Business Research Company offers the seaweed cultivation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the genetically modified crops market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the fruit and nut farming market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the forestry and logging market research report 2022 with industry size, share, segments and market growth

Global Micro-Irrigation Systems Market Outlook, Opportunities And Strategies – Includes Micro-Irrigation Systems Market Size

Global Aquaculture Market Size, Forecasts, And Opportunities – Includes Aquaculture Market Size

Vaccines Global Market Report 2022 – By Type (Anti-Infective Vaccines, Autoimmunity, Others (Cancer And Others)), By Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines), By Route of Administration (Intramuscular (IM), Subcutaneous (SC), Oral, Others), By Valance (Monovalent, Multivalent), By Distribution Channel (Institutional Sale, Hospital Pharmacies, Retail Pharmacies) – Market Size, Trends, And Global Forecast 2022-2026

View Report

Pediatric Vaccine Global Market Report 2025 – By Vaccine Type (Monovalent, Multivalent), By Technology (Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies), By Application (Infectious Disease, Allergy, Cancer) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Companion Animal Veterinary Vaccines Global Market Report 2025 – By Product (Inactivated, Live Attenuated, Recombinant, Other Products), By Route Of Administration (Oral, Parenteral, Other Routes Of Administration), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cancer Vaccines Global Market Report 2025 – By Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines), By Technology (Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector & DNA Cancer Vaccines), By Cancer Type (Prostate, Cervical, Colorectal, Throat, Other Cancer Types), By End-User (Cancer Treatment Centers, Research Institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

DTP Vaccines Global Market Report 2025 – By Product type (DTaP, TD, Tdap), By Disease (Diphtheria, Pertussis, Tetanus), By End-User (Hospitals, Clinics, Vaccination Centers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

H1N1 Vaccine Global Market Report 2025 – By Product Type( Inactivated Vaccine, Live Attenuated Vaccine ), By Route Of Administration( Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination ), By End Users( Hospitals, Clinics, Research and Diagnostic Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Meningococcal Vaccines Global Market Report 2025 – By Vaccine Type (Meningococcal Conjugate Vaccine, Polysaccharide, Subcapsular Vaccine), By Serotype (Men Acwy, Men B/Bc, Men C), By Age Group (Infants, Children, Adolescents and Young Adults, Adults), By Distribution Channel ( (Pharmacies, Community Clinics, Public Health Agencies, Other Channels), By End user (Hospitals, Research, Academic Institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Swine Vaccines Global Market Report 2025 – By Product( Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA (Deoxyribonucleic Acid) Vaccines, Recombinant Vaccines), By Disease( Viral Infections, Bacterial Infections, Parasitic Infection, Fungal Infections, Other Diseases), By Distribution Channel( Veterinary Hospitals, Veterinary Pharmacies, Online Pharmacies), By Application( Government Tender, Market Sales) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Dengue Vaccine market?

How will the Dengue Vaccine market drivers and restraints affect the market dynamics? What forces will shape the Dengue Vaccine industry going forward?

The Dengue Vaccine market major growth driver - Surge In Dengue Fever Cases Fuels Growth In The Dengue Vaccine Market. For further insights on the Dengue Vaccine market, request a sample here

What is the forecast market size or the forecast market value of the Dengue Vaccine market?

The Dengue Vaccine market size has grown strongly in recent years. The dengue vaccine market size has grown rapidly in recent years. It will grow from $0.64 billion in 2024 to $0.72 billion in 2025 at a compound annual growth rate (CAGR) of 12.4%. The growth in the historic period can be attributed to growing travel and urbanization, increasing demand for effective vaccines, increasing prevalence of foreign travel exposure, increasing healthcare services, and rising mass vaccinations. The dengue vaccine market size is expected to see rapid growth in the next few years. It will grow to $1.14 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to the increasing incidence of dengue, increasing initiatives by several organizations, increasing clinical trials, and growing emphasis on multi-strain and tetravalent vaccine formulations. Major trends in the forecast period include increasing demand for preventative vaccines, advancements in vaccine technology, development of combination vaccines, rise in research and clinical trials for new vaccine candidates, and focus on improving vaccine efficacy and safety profiles. For further insights on the Dengue Vaccine market, request a sample here

How is the Dengue Vaccine market segmented?

The dengue vaccinemarket covered in this report is segmented –
1) By Type: Live Attenuated Vaccine, Chimeric Live Attenuated Vaccine, Inactivated Vaccine, Subunit Vaccine, Nucleic Acid Based Vaccine
2) By Vaccine Phase: Phase I, Phase II, Phase III
3) By Treatment: Diuretic, Anti-Allergic, Blood Thinners, Other Treatments
4) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
5) By End-User: Hospitals, Clinics, Government Institutes, Non-Governmental Organizations, Other End-Users
Subsegments:
1) By Live Attenuated Vaccine: Single Strain, Multi-Strain
2) By Chimeric Live Attenuated Vaccine: Tetravalent Chimeric Vaccine, Monovalent Chimeric Vaccine
3) By Inactivated Vaccine: Whole Virus Inactivated Vaccine, Split Virus Vaccine
4) By Subunit Vaccine: Recombinant Protein Vaccine, Peptide-Based Vaccine
5) By Nucleic Acid Based Vaccine: DNA Vaccine, mRNA Vaccine For further insights on the Dengue Vaccine market, request a sample here

Which region has the largest share of the Dengue Vaccine market? What are the other regions covered in the report?

Asia-Pacific was the largest region in the dengue vaccine market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the dengue vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Dengue Vaccine market, request a sample here.

Who are the major players in the Dengue Vaccine market?

What are the key trends in the Dengue Vaccine market?

Major trends in the Dengue Vaccine market include Advancements In Dengue Tetravalent Vaccines Enhance Comprehensive Protection Against All Serotypes. For further insights on the Dengue Vaccine market, request a sample here.

What are the major opportunities in the Dengue Vaccine market? What are the strategies for the Dengue Vaccine market?

For detailed insights on the major opportunities and strategies in the Dengue Vaccine market, request a sample here.

How does the Dengue Vaccine market relate to the overall economy and other similar markets?

For detailed insights on Dengue Vaccine's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Dengue Vaccine industry?

For detailed insights on the mergers and acquisitions in the Dengue Vaccine industry, request a sample here.

What are the key dynamics influencing the Dengue Vaccine market growth? SWOT analysis of the Dengue Vaccine market.

For detailed insights on the key dynamics influencing the Dengue Vaccine market growth and SWOT analysis of the Dengue Vaccine industry, request a sample here.